Stop Trimethoprim-Sulfamethoxazole (Bactrim) First
When a patient is taking both trimethoprim-sulfamethoxazole (Bactrim) and lisinopril, stop the Bactrim first. This combination creates a dangerous risk of life-threatening hyperkalemia, and the antibiotic is typically the temporary medication that can be discontinued or substituted, while the ACE inhibitor is usually a chronic, essential therapy for cardiovascular protection.
Why This Combination Is Dangerous
The evidence is unequivocal about this drug interaction:
The 2019 AGS Beers Criteria explicitly warns that TMP-SMX should be used with caution in patients taking ACE inhibitors or ARBs due to increased hyperkalemia risk 1
The FDA drug label for Bactrim specifically states "avoid concurrent use" with ACE inhibitors, noting that "three cases of hyperkalemia in elderly patients have been reported after concomitant intake of BACTRIM and an angiotensin converting enzyme inhibitor" 2
Population-based research demonstrates a nearly 7-fold increased risk of hyperkalemia-associated hospitalization (adjusted OR 6.7,95% CI 4.5-10.0) when TMP-SMX is combined with ACE inhibitors or ARBs compared to other antibiotics 3
The Mechanism Behind the Risk
Trimethoprim blocks epithelial sodium channels in the distal nephron—functioning identically to the potassium-sparing diuretic amiloride 4. When combined with an ACE inhibitor (which reduces aldosterone-mediated potassium excretion), you create a perfect storm for potassium retention. The FDA label explicitly warns that trimethoprim "induces a progressive but reversible increase of serum potassium concentrations" 2.
Clinical Decision Algorithm
Step 1: Identify the indication for each medication
- If Bactrim is for an acute infection (UTI, skin infection, etc.) → Stop Bactrim immediately and substitute with an alternative antibiotic
- If lisinopril is for chronic hypertension, heart failure, or diabetic nephropathy → Continue lisinopril as these are long-term protective therapies
Step 2: Choose an alternative antibiotic
- Amoxicillin, norfloxacin, or ciprofloxacin do NOT carry the same hyperkalemia risk 3
- The population attributable fraction suggests approximately 60% of hyperkalemia cases in patients on ACE inhibitors treated for UTIs could be avoided by not prescribing TMP-SMX 5
Step 3: Monitor potassium levels
- If Bactrim must be continued for a resistant organism, check potassium within 3-5 days
- Weibull analysis shows early failure-type onset for TMP-SMX adverse events, with highest risk in the first month 6
Critical Caveats
Never stop the ACE inhibitor first unless:
- The patient has acute hyperkalemia requiring immediate intervention (K+ >6.0 mEq/L with ECG changes)
- There is no alternative antibiotic option AND the infection is not life-threatening
- The ACE inhibitor was recently started and not yet providing cardiovascular benefit
Additional risk factors that make this combination even more dangerous:
- Chronic kidney disease (CrCl <30 mL/min) 2
- Elderly patients (>75 years) 1
- Concurrent use of potassium-sparing diuretics like spironolactone (12-fold increased risk) 5
- Diabetes mellitus 3
- Dehydration or volume depletion 4
The Bottom Line
The FDA explicitly recommends avoiding this combination 2, the Beers Criteria warns against it 1, and high-quality population studies demonstrate substantial harm 3, 5. Discontinue Bactrim and substitute with an alternative antibiotic that doesn't block potassium excretion. The ACE inhibitor provides critical long-term cardiovascular and renal protection that should not be interrupted for a short-term antibiotic course when safer alternatives exist.